Victory Capital Management Inc. lifted its position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 202.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,298 shares of the company's stock after buying an additional 12,912 shares during the quarter. Victory Capital Management Inc. owned about 0.28% of Semler Scientific worth $454,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of SMLR. CWM LLC lifted its holdings in shares of Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company's stock worth $31,000 after buying an additional 744 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in Semler Scientific in the 2nd quarter worth $34,000. Quest Partners LLC bought a new position in shares of Semler Scientific during the 2nd quarter worth about $59,000. Meeder Asset Management Inc. acquired a new position in shares of Semler Scientific during the second quarter valued at about $67,000. Finally, US Bancorp DE lifted its stake in shares of Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company's stock valued at $72,000 after buying an additional 1,158 shares during the period. 49.37% of the stock is owned by institutional investors.
Semler Scientific Price Performance
Shares of Semler Scientific stock traded down $4.03 during trading on Friday, hitting $57.02. 777,423 shares of the company's stock traded hands, compared to its average volume of 260,640. The company has a market cap of $472.70 million, a PE ratio of 27.81 and a beta of 0.92. Semler Scientific, Inc. has a twelve month low of $20.88 and a twelve month high of $79.45. The firm's fifty day moving average price is $35.84 and its 200 day moving average price is $31.98.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The company had revenue of $13.51 million during the quarter.
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
